Wellceclo SP Tablet is a combination analgesic and anti-inflammatory medication containing Aceclofenac 100mg, Paracetamol 325mg, and Serratiopeptidase 10mg. Aceclofenac, a non-steroidal anti-inflammatory drug (NSAID), effectively reduces inflammation and pain by inhibiting cyclooxygenase enzymes, thereby decreasing prostaglandin synthesis. Paracetamol provides analgesic and antipyretic effects through central inhibition of prostaglandin synthesis, complementing Aceclofenac’s peripheral action. Serratiopeptidase, a proteolytic enzyme, facilitates the breakdown of inflammatory exudates and promotes the resolution of swelling and pain by enhancing tissue repair and reducing edema. This combination is indicated for the management of acute and chronic musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and postoperative inflammation, where pain and inflammation coexist. Wellceclo SP Tablet offers synergistic effects that improve patient outcomes by targeting multiple pathways involved in pain and inflammation. It should be used under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active peptic ulcer, or bleeding disorders. Caution is advised in patients with hepatic, renal, or cardiovascular impairment. Adverse effects may include gastrointestinal discomfort, allergic reactions, or mild gastrointestinal bleeding. Appropriate dosing and duration should be adhered to for optimal safety and efficacy.